A carregar...
Autofluorescence imaging captures heterogeneous drug response differences between 2D and 3D breast cancer cultures
Two-photon microscopy of cellular autofluorescence intensity and lifetime (optical metabolic imaging, or OMI) is a promising tool for preclinical drug development. OMI, which exploits the endogenous fluorescence from the metabolic coenzymes NAD(P)H and FAD, is sensitive to changes in cell metabolism...
Na minha lista:
| Publicado no: | Biomed Opt Express |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Optical Society of America
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5480588/ https://ncbi.nlm.nih.gov/pubmed/28663873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1364/BOE.8.001911 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|